Abstract |
The synthesis of a novel series of 17beta-estradiol-linked platinum(II) complexes is described. The new molecules are linked with an alkyl chain at position 16alpha of the steroid nucleus and bear a 16beta-hydroxymethyl side chain. They are made from estrone in five chemical steps with an overall yield exceeding 28%. The biological activity of these compounds was evaluated in vitro on estrogen dependent and independent (ER+ and ER-) human breast cancers. The derivatives incorporating a 2-(2'-aminoethyl)pyridine ligand displayed good activity against the cell lines particularly when the connecting arm is 10 carbon atoms long.
|
Authors | Caroline Descôteaux, Josée Provencher-Mandeville, Isabelle Mathieu, Valérie Perron, Sanat K Mandal, Eric Asselin, Gervais Bérubé |
Journal | Bioorganic & medicinal chemistry letters
(Bioorg Med Chem Lett)
Vol. 13
Issue 22
Pg. 3927-31
(Nov 17 2003)
ISSN: 0960-894X [Print] England |
PMID | 14592477
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- 17beta-estradiol platinum(II)
- Antineoplastic Agents
- Organoplatinum Compounds
- Estradiol
|
Topics |
- Antineoplastic Agents
(chemical synthesis, chemistry, toxicity)
- Breast Neoplasms
- Cell Line, Tumor
- Cell Survival
(drug effects)
- Estradiol
(analogs & derivatives, chemical synthesis, toxicity)
- Female
- Humans
- Molecular Conformation
- Organoplatinum Compounds
(chemical synthesis, chemistry, toxicity)
|